MENU
+Compare
ALBBY
Stock ticker: OTC
AS OF
Dec 17 closing price
Price
$13.54
Change
-$1.27 (-8.57%)
Capitalization
10.82B

ALBBY stock forecast, quote, news & analysis

Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on... Show more

ALBBY
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for ALBBY with price predictions
Dec 23, 2025

ALBBY's RSI Indicator is sitting in oversold zone for 4 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 55 cases where ALBBY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALBBY as a result. In of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ALBBY turned negative on December 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

The Aroon Indicator for ALBBY entered a downward trend on December 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALBBY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.376) is normal, around the industry mean (3.044). P/E Ratio (40.004) is within average values for comparable stocks, (41.455). Projected Growth (PEG Ratio) (0.813) is also within normal values, averaging (1.147). Dividend Yield (0.000) settles around the average of (0.027) among similar stocks. P/S Ratio (2.338) is also within normal values, averaging (11.433).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALBBY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
published Highlights

Industry description

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

Market Cap

The average market capitalization across the Drugstore Chains Industry is 3.42B. The market cap for tickers in the group ranges from 3.29K to 23.95B. JDHIF holds the highest valuation in this group at 23.95B. The lowest valued company is RLLVF at 3.29K.

High and low price notable news

The average weekly price growth across all stocks in the Drugstore Chains Industry was 7%. For the same Industry, the average monthly price growth was 9%, and the average quarterly price growth was 10%. PMHS experienced the highest price growth at 153%, while WGRX experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Drugstore Chains Industry was -79%. For the same stocks of the Industry, the average monthly volume growth was -24% and the average quarterly volume growth was 216%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 76
Price Growth Rating: 63
SMR Rating: 76
Profit Risk Rating: 96
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
ALBBY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry DrugstoreChains

Profile
Fundamentals
Details
Industry
N/A
Address
Guanghua Road
Phone
N/A
Employees
1560
Web
https://www.alihealth.cn